AQR Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $124K | Buy |
18,053
+445
| +3% | +$3.06K | ﹤0.01% | 3145 |
|
2025
Q1 | $50.7K | Sell |
17,608
-28,033
| -61% | -$80.7K | ﹤0.01% | 3081 |
|
2024
Q4 | $215K | Sell |
45,641
-52,835
| -54% | -$248K | ﹤0.01% | 2648 |
|
2024
Q3 | $352K | Buy |
+98,476
| New | +$352K | ﹤0.01% | 2320 |
|
2022
Q3 | – | Sell |
-13,966
| Closed | -$68K | – | 2243 |
|
2022
Q2 | $68K | Buy |
+13,966
| New | +$68K | ﹤0.01% | 2118 |
|
2022
Q1 | – | Sell |
-14,024
| Closed | -$248K | – | 2241 |
|
2021
Q4 | $248K | Buy |
+14,024
| New | +$248K | ﹤0.01% | 2029 |
|